Classifying extracranial large-vessel giant cell arteritis using the new 2022 American College of Rheumatology/EULAR classification criteria: comment on the article by Ponte et al

被引：0

作者：

Castaneda, Santos ^{[1
,2
]}

Vicente-Rabaneda, Esther F. ^{[1
]}

Gonzalez-Gay, Miguel A. ^{[3
,4
,5
]}

机构：

[1] Hosp Univ Princesa, Rheumatol Dept, Fdn Invest Biomed, Inst Invest Sanitaria Princesa, Madrid, Spain

[2] Univ Autonoma Madrid, EPID Future, Catedra UAM Roche, Med, Madrid, Spain

[3] Fdn Jimenez Diaz, IIS FJD, Rheumatol Dept, Madrid, Spain

[4] Inst Invest Valdecilla IDIVAL Cantabria, Epidemiol Genet & Atherosclerosis Res Grp Syst In, Santander, Spain

[5] Univ Cantabria, Santander, Spain

来源：

ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷 / 06期

关键词：

D O I：

10.1002/art.42439

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1077 / 1077

页数：1

共 33 条

[21] LONG-TERM SURVIVAL OF PATIENTS WITH GIANT-CELL ARTERITIS FROM THE AMERICAN-COLLEGE-OF-RHEUMATOLOGY GIANT-CELL ARTERITIS CLASSIFICATION CRITERIA COHORT
MATTESON, EL
GOLD, KN
BLOCH, DA
HUNDER, GG
ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 633 - 633
[22] Comment on: Diagnostic accuracy of ultrasound for detecting large-vessel giant cell arteritis using FDG PET/CT as the reference
Tomelleri, Alessandro
Sebastian, Alwin
Dasgupta, Bhaskar
RHEUMATOLOGY, 2021, 60 (02) : E66 - E66
[23] Performance of the new 2022 ACR/EULAR classification criteria for giant cell arteritis in clinical practice in relation to its clinical phenotypes
Narvaez, Javier
Estrada, Paula
Vidal-Montal, Paola
Nolla, Joan Miquel
AUTOIMMUNITY REVIEWS, 2023, 22 (10)
[24] Response to: Correspondence on "European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance" by Bossuyt et al
Aringer, Martin
Costenbader, Karen
Leuchten, Nicolai
Dorner, Thomas
Johnson, Sindhu R.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (08)
[25] How can misclassification be prevented when using the 2010 American College of Rheumatology/European League Against Rheumatism rheumatoid arthritis classification criteria? Comment on the article by van der Linden et al
Zeidler, Henning
ARTHRITIS AND RHEUMATISM, 2011, 63 (08): : 2544 - 2546
[26] How can misclassification be prevented when using the 2010 American College of Rheumatology/European League Against Rheumatism rheumatoid arthritis classification criteria? Comment on the article by van der Linden et al Reply
van der Linden, M. P.
van der Helm-van Mil, A. H.
ARTHRITIS AND RHEUMATISM, 2011, 63 (08): : 2546 - 2546
[27] Exclusion of cutaneous lupus erythematosus subtypes from the 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus: comment on the article by Aringer et al
Zapata, Lucio, Jr.
Chong, Benjamin F.
ARTHRITIS & RHEUMATOLOGY, 2020, 72 (08) : 1403 - 1404
[28] The 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis should include new standards for hepatitis B screening: comment on the article by Singh et al
Calabrese, Leonard H.
Calabrese, Cassandra
Kirchner, Elizabeth
ARTHRITIS CARE & RESEARCH, 2016, 68 (05) : 723 - 724
[29] The 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis should include new standards for hepatitis B screening: comment on the article by Singh et al
Calabrese, Leonard H.
Calabrese, Cassandra
Kirchner, Elizabeth
ARTHRITIS & RHEUMATOLOGY, 2016, 68 (05) : 1314 - 1315
[30] Does leukopenia influence performance of the new European League Against Rheumatism/American College of Rheumatology classification criteria in an African-descendent population with childhood-onset systemic lupus erythematosus? Comment on the article by Aringer et al
Fonseca, Adriana R.
Rodrigues, Marta C. F.
Sztajnbok, Flavio
Land, Marcelo G. P.
de Oliveira, Sheila K. F.
ARTHRITIS & RHEUMATOLOGY, 2020, 72 (04) : 694 - 695

← 1 2 3 4 →